Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart

被引:32
作者
Chen, Lei [14 ]
Tonkin, Andrew M. [14 ]
Moon, Lynelle [10 ]
Mitchell, Paul [9 ]
Dobson, Annette [7 ]
Giles, Graham [13 ]
Hobbs, Michael [6 ]
Phillips, Patrick J. [5 ]
Shaw, Jonathan E. [12 ]
Simmons, David [4 ,11 ]
Simons, Leon A. [8 ]
Fitzgerald, Anthony P. [2 ,3 ]
De Backer, Guy [1 ]
De Bacquer, Dirk [1 ]
机构
[1] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium
[2] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland
[4] Inst Metab Sci, Cambridge, England
[5] Queen Elizabeth Hosp, Dept Endocrinol, Adelaide, SA, Australia
[6] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
[7] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[8] Univ New S Wales, Lipid Res Dept, St Vincents Hosp, Sydney, NSW, Australia
[9] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Sydney, NSW 2006, Australia
[10] Australian Inst Hlth & Welf, Canberra, ACT, Australia
[11] Univ Melbourne, Dept Rural Hlth, Melbourne, Vic, Australia
[12] Univ Melbourne, Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[13] Univ Melbourne, Canc Council Victoria, Melbourne, Vic, Australia
[14] Univ Melbourne, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2009年 / 16卷 / 05期
关键词
Blue Mountains Eye Study; cardiovascular disease; mortality; risk prediction; Systematic COronary Risk Evaluation; CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; CLINICAL-PRACTICE; PARTICIPANTS; HEALTH; MORTALITY; ACCURACY; PROJECT; TESTS; WOMEN;
D O I
10.1097/HJR.0b013e32832cd9cb
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Development of a validated risk prediction model for future cardiovascular disease (CVD) in Australians is a high priority for cardiovascular health strategies. Design Recalibration of the SCORE (Systematic COronary Risk Evaluation) risk chart based on Australian national mortality data and average major CVD risk factor levels. Methods Australian national mortality data (2003-2005) were used to estimate 10-year cumulative CVD mortality rates for people aged 40-74 years. Average age-specific and sex-specific levels of systolic blood pressure, total cholesterol and prevalence of current smoking were generated from data obtained in eight Australian large-scale population-based surveys undertaken from the late 1980s. The SCORE risk chart was then recalibrated by applying hazard ratios for 10-year CVD mortality obtained in the SCORE project. Discrimination and calibration of the recalibrated model was evaluated and compared with that of the original SCORE and Framingham equations in the Blue Mountains Eye Study in Australia using Harrell's c and Hosmer-Lemeshow chi(2) statistics, respectively. Results An Australian risk prediction chart for CVD mortality was derived. Among 1998 Blue Mountains Eye Study participants aged 49-74 years with neither CVD nor diabetes at baseline, the Harrell's c statistics for the Australian risk prediction chart for CVD mortality were 0.76 (95% confidence interval: 0.69-0.84) and 0.71 (confidence interval: 0.62-0.80) in men and women, respectively. The corresponding Hosmer-Lemeshow chi(2) statistics, the measure of calibration, were 2.32 (P=0.68) and 7.43 (P=0.11), which were superior to both the SCORE and Framingham equations. Conclusion This new tool provides a valid and reliable method to predict risk of CVD mortality in the general Australian population. Eur J Cardiovasc Prev Rehabil 16:562-570 (C) 2009 The European Society of Cardiology
引用
收藏
页码:562 / 570
页数:9
相关论文
共 29 条
[1]  
Access Economics, 2005, SHIFT BURD CARD DIS
[2]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[3]  
*AUSTR BUR STAT, 2006, 32010 ABS
[4]  
*AUSTR BUR STAT, 2004, 32010 ABS
[5]  
*AUSTR BUR STAT, 2005, 32010 ABS
[6]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[7]   Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality [J].
De Bacquer, Dirk ;
De Backer, Guy .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 143 (03) :385-390
[8]   Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease [J].
Devers, M. C. ;
Campbell, S. ;
Shaw, J. ;
Zimmet, P. ;
Simmons, D. .
DIABETIC MEDICINE, 2008, 25 (05) :523-529
[9]   Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project [J].
Dobson, AJ ;
Evans, A ;
Ferrario, M ;
Kuulasmaa, KA ;
Moltchanov, VA ;
Sans, S ;
Tunstall-Pedoe, H ;
Tuomilehto, JO ;
Wedel, H ;
Yarnell, J .
ANNALS OF MEDICINE, 1998, 30 (02) :199-205
[10]   The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
Cameron, AJ ;
Shaw, J ;
de Courten, M ;
Jolley, D ;
McCarty, DJ .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) :119-129